EP 3923956 A1 20211222 - METHOD FOR ENHANCING ?ETA-ADRENERGIC RESPONSE
Title (en)
METHOD FOR ENHANCING ?ETA-ADRENERGIC RESPONSE
Title (de)
VERFAHREN ZUR VERBESSERUNG DER BETA-ADRENERGISCHEN ANTWORT
Title (fr)
PROCÉDÉ D'AMÉLIORATION DE LA RÉPONSE ?ÊTA-ADRÉNERGIQUE
Publication
Application
Priority
- IS 9111 A 20190211
- IS 2020050001 W 20200211
Abstract (en)
[origin: WO2020165925A1] The present invention provides cnidimoside A for use in the treatment of urinary conditions such as overactive bladder and related syndromes. The invention also relates to methods of treatment of overactive bladder using cnidimoside A. The compound can be administered purified or as a plant extract.
IPC 8 full level
A61K 31/7048 (2006.01); A61K 9/00 (2006.01); A61K 36/232 (2006.01); A61K 36/234 (2006.01); A61K 36/505 (2006.01); A61K 36/66 (2006.01); A61P 13/10 (2006.01)
CPC (source: EP KR US)
A61K 9/48 (2013.01 - US); A61K 31/7048 (2013.01 - EP KR US); A61K 36/232 (2013.01 - EP KR US); A61K 36/234 (2013.01 - EP KR US); A61K 36/50 (2013.01 - KR); A61K 36/505 (2013.01 - EP US); A61K 36/66 (2013.01 - EP); A61P 13/10 (2018.01 - EP KR US)
Citation (examination)
WO 2017164707 A1 20170928 - KEMIMEDI CO LTD [KR], et al
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020165925 A1 20200820; CA 3127291 A1 20200820; CN 113710252 A 20211126; EP 3923956 A1 20211222; KR 20210126082 A 20211019; US 11850257 B2 20231226; US 2022202840 A1 20220630
DOCDB simple family (application)
IS 2020050001 W 20200211; CA 3127291 A 20200211; CN 202080013481 A 20200211; EP 20710304 A 20200211; KR 20217029097 A 20200211; US 202017429695 A 20200211